Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $45 | $30 | $24 | $33 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $61 | $72 | $54 | $51 |
| Inventory | $108 | $101 | $93 | $73 |
| Other Curr. Assets | $32 | $15 | $11 | $11 |
| Total Curr. Assets | $247 | $218 | $183 | $167 |
| Property Plant & Equip (Net) | $168 | $154 | $127 | $101 |
| Goodwill | $28 | $33 | $35 | $45 |
| Intangibles | $18 | $18 | $18 | $9 |
| Long-Term Investments | $3 | $3 | $1 | $1 |
| Tax Assets | $6 | $0 | $5 | $5 |
| Other NC Assets | $0 | $6 | $2 | $2 |
| Total NC Assets | $224 | $213 | $188 | $163 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $471 | $431 | $371 | $330 |
| Liabilities | – | – | – | – |
| Payables | $27 | $27 | $31 | $17 |
| Short-Term Debt | $24 | $13 | $23 | $65 |
| Tax Payable | $5 | $8 | $1 | $4 |
| Deferred Revenue | $0 | $8 | $14 | $16 |
| Other Curr. Liab. | $32 | $45 | $9 | $13 |
| Total Curr. Liab. | $88 | $80 | $79 | $115 |
| LT Debt | $207 | $189 | $150 | $79 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $6 | $6 | $4 |
| Total NC Liab. | $211 | $195 | $156 | $83 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13 | $0 | $0 | $0 |
| Total Liabilities | $299 | $275 | $234 | $198 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $5 | $5 | $5 |
| Retained Earnings | $151 | $134 | $121 | $122 |
| AOCI | $14 | $14 | $9 | $3 |
| Other Equity | $2 | $2 | $2 | $2 |
| Total Equity | $172 | $156 | $137 | $132 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $471 | $431 | $371 | $330 |
| Net Debt | $186 | $173 | $149 | $111 |